ABBV

ABBVie Inc discovers develops manufactures and sells pharmaceuticals in the worldwide The company offers HUMIRA a therapy administered as an injection for autoimmune and intestinal Behcets diseases SKYRIZI to treat moderate to severe plaque psoriasis in adults RINVOQ a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients IMBRUVICA to treat adult patients with chronic lymphocytic leukemia CLL small lymphocytic lymphoma SLL and VENCLEXTA a BCL2 inhibitor used to treat adults with CLL or SLL and MAVYRET to treat patients with chronic HCV genotype 16 infection It also provides CREON a pancreatic enzyme therapy for exocrine pancreatic insufficiency Synthroid used in the treatment of hypothyroidism LinzessConstella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation Lupron for the palliative treatment of advanced prostate cancer endometriosis and central precocious puberty and patients with anemia caused by uterine fibroids and Botox therapeutic In addition the company offers ORILISSA a nonpeptide small molecule gonadotropinreleasing hormone antagonist for women with moderate to severe endometriosis pain Duopa and Duodopa a levodopacarbidopa intestinal gel to treat Parkinsons disease LumiganGanfort a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure IOP in patients with open angle glaucoma OAG or ocular hypertension Ubrelvy to treat migraine with or without aura in adults Alphagan Combigan an alphaadrenergic receptor agonist for the reduction of IOP in patients with OAG and Restasis a calcineurin inhibitor immunosuppressant to increase tear production as well as other eye care products ABBVie Inc has a research collaboration with Dragonfly Therapeutics Inc The company was incorporated in 2012 and is headquartered in North Chicago Illinois